Longeveron LLC reports a Return on Equity (ROE) of -139.95%.

What is LGVN's dividend yield?

Longeveron LLC offers a dividend yield of 0.00%.

What is LGVN's Quality Score?

Our AI rates LGVN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy LGVN?

Our AI Timing Score for LGVN is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does LGVN belong to?

Longeveron LLC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Longeveron LLC (LGVN) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

LGVN AI Analysis Summary

Our AI summary for LGVN: Longeveron LLC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -139.95%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LGVN

Longeveron LLC

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 0.73

0.03 (4.35%) Day Change

Watchlist Portfolio Compare Chart

0.04

D/E

-140.0%

ROE

-105.8%

ROA

0.00%

Div Yield

LONGEVERON LLC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.73 Price 0.03 (4.35%) Day Change	NEWS SCORE: 91

LGVN, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.73
PBV / Sector	1.38 / 44,219.29 GOOD
Earning Per Share	-0.74

PE / Sector	N/A / 19.28
PEG or PE/Growth / Sector	N/A / 1.23
Average 1M Daily Value	0.13 M GREAT
Average 1W Daily Value	0.22 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,844.49 / 98.22
NPM Average (%) / Sector	-1,793.47 / -1,697.63
NPM Change Average (%) / Sector	49.76 / 5,097.97 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-105.75 / 185,260.96
ROA Average (%) / Sector	-127.10 / 36,684.70
ROA Change Average (%) / Sector	73.78 / 422,221.66 GREAT
ROE (%) / Sector	-139.95 / 243,762.23
ROE Average (%) / Sector	-204.50 / 48,758.47
ROE Change Average (%) / Sector	137.98 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

Registration Details

Analyze Date	2026-08-04 08:01:47
Symbol	LGVN
Name	LONGEVERON LLC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	30.15 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	22.17 / 9,645.64

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Life Science & Technology Park, Miami, FL, United States, 33136

Phone: 844 470 2550

Website: https://longeveron.com

Sector: Healthcare >> Biotechnology

Description: Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.